如何使用与解读平台试验结果:医学文献使用者指南
平台试验是一种随机临床试验,可同时比较多个干预组与单一共同对照组,基于预设期中分析计划进行。平台试验设计允许在试验启动后引入新干预措施,通过单一总体方案(主方案)持续评估多种干预。本文旨在描述平台试验与主方案的基本概念,并回顾其实施与解读中的问题,帮助临床医生和读者理解采用平台试验设计评估干预措施的文章。
要点
- 平台试验可同时比较多个干预组与单一共同对照组,基于预设期中分析计划。
- 平台试验允许在试验启动后引入新干预,使用单一主方案持续评估多种干预。
- 本文旨在帮助临床医生和读者理解采用平台试验设计评估干预的文章。
核心结论
- 平台试验在创建高效试验基础设施方面具有重要潜在优势,可随证据演变帮助解决关键临床问题。
研究设计与样本
- 本文为医学文献使用者指南,描述平台试验和主方案的基本概念,并回顾其实施与解读中的问题。
主要发现
- 平台试验允许同时比较多个干预组与单一共同对照组,基于预设期中分析计划进行。
- 平台试验设计允许在试验启动后引入新干预措施,通过单一总体方案(主方案)持续评估多种干预。
- 当多种治疗候选方案可用时,平台试验可能加快科学治疗发现的进程。
- 平台试验近期已用于研究COVID-19患者不断演变的治疗手段。
临床怎么用
- 本文旨在帮助临床医生和读者理解采用平台试验设计评估干预措施的文章。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Platform trials are a type of randomized clinical trial that allow simultaneous comparison of multiple intervention groups against a single control group that serves as a common control based on a prespecified interim analysis plan. The platform trial design enables introduction of new interventions after the trial is initiated to evaluate multiple interventions in an ongoing manner using a single overarching protocol called a master (or core) protocol. When multiple treatment candidates are available, rapid scientific therapeutic discoveries may be made. Platform trials have important potential advantages in creating an efficient trial infrastructure that can help address critical clinical questions as the evidence evolves. Platform trials have recently been used in investigations of evolving therapies for patients with COVID-19. The purpose of this Users' Guide to the Medical Literature is to describe fundamental concepts of platform trials and master protocols and review issues in the conduct and interpretation of these studies. This Users' Guide is intended to help clinicians and readers understand articles reporting on interventions evaluated using platform trial designs.
引用
- Park JJH, Detry MA, Murthy S, et al. How to Use and Interpret the Results of a Platform Trial: Users' Guide to the Medical Literature. JAMA. 2022. PMID: 34982138. doi:10.1001/jama.2021.22507
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。